JAZZ vs SOC · P/E 1988, rev $2.28B vs rev $137.1M
Jazz Pharmaceuticals PLC (JAZZ) versus Sable Offshore Corp. (SOC) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Sable Offshore Corp. (SOC) is a oil & gas drilling company listed on NYSE.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SOC revenue for 2026-06-30 was $137.1M. Net income was -$64.2M. SOC currently screens at market cap $1.58B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SOC currently screens at market cap $1.58B.
Not investment advice. Open the JAZZ and SOC stock pages for the full models.
Not investment advice.